Skip to main content

Leco, Berkeley National Lab Partner on Metabolomics

NEW YORK (GenomeWeb News) – Analytical instrument firm Leco announced today an agreement with the US Department of Energy's Lawrence Berkeley National Laboratory to develop metabolomic applications and tools.

The deal provides Berkeley Lab's Life Sciences Division access to Leco's Citius LC-High Resolution TOF-MS. The instrument provides acquisition speeds of up to 200 spectra per second, mass resolution up to 100,000 full width at half maximum (FWHM) and mass accuracy less than 1 parts per million, Leco said.

Trent Northen, a staff scientist at Berkeley Labs Life Sciences Division and the Joint BioEnergy Institute, will direct the research, which focuses on constructing detailed models of cellular communities' metabolism and energy. Metabolite imaging and metabolomic analysis will be conducted to build the models, and applications of the research will go toward elucidating the dynamics of microbial communities and the metabolic drivers of breast cancer.

Terms of the deal were not disclosed.

Last week, Leco and Genedata announced an agreement to market Genedata Expressionist MSX software compatibility with Leco's HR TOF-MS instrument.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.